Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Bleomycin A2
RN: 11116-31-7
UNII: 13M89UEA7W
InChIKey: OYVAGSVQBOHSSS-UAPAGMARSA-N

Note

  • A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.

Molecular Formula

  • C55-H84-N17-O21-S3

Molecular Weight

  • 1414.5567
 

Classification Codes

  • Antineoplastic Agents
  • Drug / Therapeutic Agent
  • Human Data
  • Mutation Data
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Bleomycin A2

Name of Substance

  • Bleomycinamide, N1-(3-(dimethylsulfonio)propyl)-

Synonyms

  • Bleogin
  • Bleomycin A2
  • EINECS 234-356-5
  • N1-(3-(Dimethylsulfonio)propyl)bleomycinamide
  • Pingyangmycin A2
  • UNII-13M89UEA7W
  • Zhengguangmycin A2
  • Zhengguangmycin A2 [Chinese]

Systematic Names

  • Bleomycin A2
  • Bleomycinamide, N1-(3-(dimethylsulfonio)propyl)-

Registry Numbers

CAS Registry Number

  • 11116-31-7

FDA UNII

  • 13M89UEA7W

Other Registry Numbers

  • 11032-70-5
  • 1247874-09-4
  • 69215-21-0
  • 754126-85-7

System Generated Number

  • 0011116317

Structure Descriptors

InChI

1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1

InChIKey

OYVAGSVQBOHSSS-UAPAGMARSA-N

Smiles

C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]3O)c4cnc[n-]4)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCC[S+](C)C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo intravenous 2143ug/kg (2.143mg/kg) LUNGS, THORAX, OR RESPIRATION: FIBROSING ALVEOLITIS Cancer Research. Vol. 36, Pg. 1267, 1976.
mouse LD50 intraperitoneal 130mg/kg (130mg/kg)   Yaoxue Xuebao. Acta Pharmaceutica Sinica. Pharmaceutical Journal. Vol. 14, Pg. 83, 1979.
mouse LD50 intravenous 100mg/kg (100mg/kg)   Yaoxue Xuebao. Acta Pharmaceutica Sinica. Pharmaceutical Journal. Vol. 14, Pg. 83, 1979.